NCT02026336
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +10 more
- Locations
-
- Vicente Plaza Barcelona, Spain
Clinical trial condition
Lung Diseases, Obstructive
Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.
7,958 public trials
738 recruiting studies
Lung Diseases, Obstructive trial results
NCT01664767
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +7 more
- Locations
-
- Research Centre on Asthma and COPD, University of Ferrara Ferrara, Italy
NCT00465959
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- United States Investigational Site Spartanburg, South Carolina, United States
NCT01285492
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
- Locations
-
- Novartis Investigative Site Anjo, Aichi-ken, Japan
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Nishio, Aichi-ken, Japan
- Novartis Investigative Site Akita, Japan
NCT01072396
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- 205.440.1006 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
- 205.440.1015 Boehringer Ingelheim Investigational Site Jasper, Alabama, United States
- 205.440.1002 Boehringer Ingelheim Investigational Site Torrance, California, United States
- 205.440.1018 Boehringer Ingelheim Investigational Site Hartford, Connecticut, United States
NCT00530842
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- 205.334.4309 Boehringer Ingelheim Investigational Site Gänserndorf, Austria
- 205.334.4308 Boehringer Ingelheim Investigational Site Hallein, Austria
- 205.334.4306 Boehringer Ingelheim Investigational Site Leoben, Austria
- 205.334.4301 Boehringer Ingelheim Investigational Site Linz, Austria
NCT00563381
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- 205.389.1020 Boehringer Ingelheim Investigational Site Feldbach, Austria
- 205.389.1010 Boehringer Ingelheim Investigational Site Feldkirch, Austria
- 205.389.1003 Boehringer Ingelheim Investigational Site Gänserndorf, Austria
- 205.389.1011 Boehringer Ingelheim Investigational Site Grimmenstein/Hochegg, Austria
NCT01233284
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- 205.380.43002 Boehringer Ingelheim Investigational Site Hallein, Austria
- 205.380.43004 Boehringer Ingelheim Investigational Site Linz, Austria
- 205.380.43005 Boehringer Ingelheim Investigational Site Neumarkt am Wallersee, Austria
- 205.380.43001 Boehringer Ingelheim Investigational Site Schlüsslberg, Austria
NCT00350207
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- 205.342.43002 Boehringer Ingelheim Investigational Site Graz, Austria
- 205.342.43004 Boehringer Ingelheim Investigational Site Trofaiach, Austria
- 205.342.43001 Boehringer Ingelheim Investigational Site Vienna, Austria
- 205.342.43005 Boehringer Ingelheim Investigational Site Vienna, Austria
Completed
Tiotropium In Exercise
NCT00525512
- Conditions
- Behavior, Chronic Disease, Disease Attributes, +8 more
- Locations
-
- 205.368.01023 Boehringer Ingelheim Investigational Site Jasper, Alabama, United States
- 205.368.01022 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
- 205.368.01003 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
- 205.368.01008 Boehringer Ingelheim Investigational Site Fort Collins, Colorado, United States